Recent advance of fluorescent probes for detection of drug-induced liver injury markers

被引:21
|
作者
Sun, Dongqin [1 ]
Chen, Zhenzhen [1 ]
Hu, Jiali [1 ]
Zeng, Huajin [1 ]
Qu, Lingbo [2 ]
Yang, Ran [2 ]
机构
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Coll Chem, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
Fluorescent probe; Drug-induced liver injury (DILI); Roussel uclaf causality assessment method (RUCAM); Clinical markers; Imaging; GLUTATHIONE-S-TRANSFERASE; IMAGING ENDOGENOUS PEROXYNITRITE; HIGHLY SELECTIVE DETECTION; ALANINE AMINOTRANSFERASE; INDUCED HEPATOTOXICITY; ENDOPLASMIC-RETICULUM; BIOLUMINESCENT PROBE; CAUSALITY ASSESSMENT; HYPOCHLOROUS ACID; ADVERSE REACTIONS;
D O I
10.1016/j.cclet.2021.12.043
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-induced liver injury (DILI) is a common and serious adverse drug reaction. At present, DILI is perfectly diagnozed in clinical settings using Roussel Uclaf causality assessment method (RUCAM) in its original version published 1993 and its updated version published 2016, well established worldwide as a diagnostic algorithm with a high sensitivity and specificity. Nevertheless, the search for additional detection methods supporting RUCAM continues. In recent years, with the development of optical imaging technology, fluorescent probes have gradually shown great advantages in the detection and diagnosis of DILI markers such as high sensitivity, anti-interference, real-time monitoring and non-invasive measurement. In this review, the recent advances of fluorescent probes for evaluation of DILI in experimental studies were summarized according to various markers of DILI. We believe that learning about the design and practical application of these probes will contribute to the further development of detection sensors for DILI markers. (C) 2022 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页码:4478 / 4494
页数:17
相关论文
共 50 条
  • [41] Optimizing phenyl selenide-based BODIPYs as fluorescent probes for diagnosing cancer and drug-induced liver injury via cysteine
    Lu, Xiaoyan
    Wang, Nannan
    Tao, Yuanfang
    Wang, Jiamin
    Ji, Xin
    Liu, Jinying
    Zhao, Weili
    Zhang, Jian
    CHEMICAL COMMUNICATIONS, 2022, 58 (90) : 12576 - 12579
  • [42] Hepatitis E Masquerading as Drug-Induced Liver Injury
    Chen, Emerson Y.
    Baum, Karl
    Collins, William
    Loeve, Arthur
    Merz, Michael
    Olafsson, Sigurdur
    Bjoernsson, Einar S.
    Lee, William M.
    HEPATOLOGY, 2012, 56 (06) : 2420 - 2423
  • [43] Rational Design of an Intramolecular Hydrogen Bond Enhanced Fluorescent Probe for Diagnosis of Drug-Induced Liver Injury
    Chen, Xue
    Shi, Lei
    Ran, Xiao-Yun
    Zhang, Li-Na
    Xie, Kun-Peng
    Zhao, Yu
    Chen, Jie
    Ye, Ling
    Yu, Xiao-Qi
    Li, Kun
    ACS MATERIALS LETTERS, 2024, 6 (03): : 1059 - 1068
  • [44] Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond
    Gu, Ruizhi
    Liang, Alina
    Liao, Grace
    To, Isabelle
    Shehu, Amina
    Ma, Xiaochao
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (05) : 646 - 654
  • [45] γ-Glutamyltranspeptidase-Activated Near-Infrared fluorescent probe for visualization of Drug-Induced liver injury
    Liu, Feiyan
    Li, Yalin
    Zhu, Jiangmin
    Li, Yin
    Zhu, Dongrong
    Luo, Jianguang
    Kong, Lingyi
    BIOORGANIC CHEMISTRY, 2023, 141
  • [46] Endoplasmic reticulum-targeted fluorescent probe with aggregation-induced emission features for imaging peroxynitrite in drug-induced liver injury model
    Zhang, Haixia
    Yang, Yating
    Xie, Feiran
    Lan, Yu
    Li, Lin
    Song, Zhenlei
    Gao, Lu
    Huang, Yi
    Xiao, Peihong
    BIOSENSORS & BIOELECTRONICS, 2024, 262
  • [47] Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation
    McGill, Mitchell R.
    Jaeschke, Hartmut
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (09) : 797 - 807
  • [48] Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury
    Jing, Jing
    Teschke, Rolf
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (01) : 57 - 68
  • [49] Secondary sclerosing cholangitis in patients with drug-induced liver injury
    Gudnason, Hafsteinn O.
    Bjornsson, Helgi K.
    Gardarsdottir, Marianna
    Thorisson, Hjalti M.
    Olafsson, Sigurdur
    Bergmann, Ottar M.
    Bjornsson, Einar S.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (06) : 502 - 507
  • [50] Drug-Induced Liver Injury Is a Major Risk for New Drugs
    Seeff, Leonard B.
    DIGESTIVE DISEASES, 2015, 33 (04) : 458 - 463